Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

EGFR-TKI

  • You have access
    Prognosis of EGFR-mutant Lung Adenocarcinoma Patients With Malignant Pleural Effusion Receiving First-line EGFR-TKI Therapy Without Pleurodesis: A Single-institute Retrospective Study
    KOSUKE KASHIWABARA, SHINJI FUJI, SHINSUKE TSUMURA and KAZUHIKO SAKAMOTO
    Anticancer Research February 2020, 40 (2) 1117-1121; DOI: https://doi.org/10.21873/anticanres.14051
  • You have access
    Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer
    EISUKE KURIHARA, KAZUHIKO SHIEN, HIDEJIRO TORIGOE, TATSUAKI TAKEDA, YUTA TAKAHASHI, YUSUKE OGOSHI, TAKAHIRO YOSHIOKA, KEI NAMBA, HIROKI SATO, KEN SUZAWA, HIROMASA YAMAMOTO, JUNICHI SOH, MIKIO OKAZAKI, TADAHIKO SHIEN, SHUTA TOMIDA and SHINICHI TOYOOKA
    Anticancer Research April 2019, 39 (4) 1767-1775; DOI: https://doi.org/10.21873/anticanres.13283
  • You have access
    Identification of Genomic Alterations Acquired During Treatment With EGFR-TKIs in Non-small Cell Lung Cancer
    NAOKI KUBO, TAISHI HARADA, YOSHIMASA SHIRAISHI, KANAME NOSAKI, NORIAKI NAKAGAKI, MASAFUMI TAKESHITA, HIROSHI OUCHI, EIJI IWAMA, KENTARO TANAKA, ISAMU OKAMOTO, HIROYUKI SASAKI and YOICHI NAKANISHI
    Anticancer Research February 2019, 39 (2) 671-677; DOI: https://doi.org/10.21873/anticanres.13162
  • You have access
    Acquired EGFR T790M Mutation After Relapse Following EGFR-TKI Therapy: A Population-based Multi-institutional Study
    TAKAYUKI KABURAGI, MORIYUKI KIYOSHIMA, TAKESHI NAWA, HIDEO ICHIMURA, TAKEFUMI SAITO, KENJI HAYASHIHARA, HIDEYASU YAMADA, HIROAKI SATOH, TAKEO ENDO, YOSHIHISA INAGE, KAZUHITO SAITO, MASAHARU INAGAKI, NOBUYUKI HIZAWA, YUKIO SATO, HIROICHI ISHIKAWA, MITSUAKI SAKAI, KOICHI KAMIYAMA, NORIHIRO KIKUCHI, HIROYUKI NAKAMURA, KINYA FURUKAWA, TAKAHIDE KODAMA, TAKAAKI YAMASHITA, AKIHIRO NOMURA and SUSUMU YOSHIDA
    Anticancer Research May 2018, 38 (5) 3145-3150;
  • You have access
    Prognostic Significance of NSCLC and Response to EGFR-TKIs of EGFR-Mutated NSCLC Based on PD-L1 Expression
    KENICHI KOBAYASHI, MASAHIRO SEIKE, FENFEI ZOU, RINTARO NORO, MIKA CHIBA, ARIMI ISHIKAWA, SHINOBU KUNUGI, KAORU KUBOTA and AKIHIKO GEMMA
    Anticancer Research February 2018, 38 (2) 753-762;
  • You have access
    Predictive and Prognostic Value of CYFRA 21-1 for Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs
    AKIRA TAKEUCHI, TETSUYA OGURI, KAZUKI SONE, KEIMA ITO, YUKI KITAMURA, YOSHITSUGU INOUE, TAKAMITSU ASANO, SATOSHI FUKUDA, YOSHIHIRO KANEMITSU, OSAMU TAKAKUWA, HIROTSUGU OHKUBO, MASAYA TAKEMURA, KEN MAENO, YUTAKA ITO and AKIO NIIMI
    Anticancer Research October 2017, 37 (10) 5771-5776;
  • You have access
    EGFR T790M Detection in Circulating Tumor DNA from Non-small Cell Lung Cancer Patients Using the PNA-LNA Clamp Method
    HIRONORI YOSHIDA, YOUNG HAK KIM, HIROAKI OZASA, HIROKI NAGAI, YUICHI SAKAMORI, TAKAHIRO TSUJI, TAKASHI NOMIZO, TOMOKO FUNAZO, YUTO YASUDA and TOYOHIRO HIRAI
    Anticancer Research May 2017, 37 (5) 2721-2725;
  • You have access
    Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib
    ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, ONDREJ TOPOLCAN, JAROSLAV RACEK, MARTIN SVATON, RADEK KUCERA, MAREK MINARIK, LUCIE BENESOVA, ZBYNEK BORTLICEK, RENATA CHLOUPKOVA, ALEXANDR POPRACH and TOMAS BUCHLER
    Anticancer Research May 2016, 36 (5) 2459-2465;
  • You have access
    Effectiveness of Tyrosine Kinase Inhibitors in Japanese Patients with Non-small Cell Lung Cancer Harboring Minor Epidermal Growth Factor Receptor Mutations: Results from a Multicenter Retrospective Study (HANSHIN Oncology Group 0212)
    TOMOYUKI OTSUKA, MASAHIDE MORI, YUKIHIRO YANO, JUNJI UCHIDA, KAZUMI NISHINO, REIKO KAJI, AKITO HATA, YOSHIHIRO HATTORI, YOSHIKO URATA, TOSHIHIKO KANEDA, MOTOKO TACHIHARA, FUMIO IMAMURA, NOBUYUKI KATAKAMI, SHUNICHI NEGORO, SATOSHI MORITA and SOICHIRO YOKOTA
    Anticancer Research July 2015, 35 (7) 3885-3891;
  • You have access
    The Role of Neuron-specific Enolase (NSE) and Thimidine Kinase (TK) Levels in Prediction of Efficacy of EGFR-TKIs in Patients with Advanced-stage NSCLC
    ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, LUCIE BENESOVA, MAREK MINARIK, ZBYNEK BORTLICEK and ONDREJ TOPOLCAN
    Anticancer Research September 2014, 34 (9) 5193-5198;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire